The trial found that TXA significantly reduced death due to bleeding.
Despite the reduction in mortality, the trial did not show a decrease in the rate of hysterectomies. woman trial txa
If you meant a trial on TXA in women for another condition (e.g., heavy menstrual bleeding, trauma, surgery), let me know and I can provide the specific paper. The trial found that TXA significantly reduced death
For women treated with TXA within three hours of birth, the risk of death due to bleeding was reduced by 31% (RR 0.69; 95% CI 0.52–0.91). For women treated with TXA within three hours
A major concern prior to the trial was whether TXA might increase the risk of blood clots (thrombosis), such as Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE), as pregnancy is already a hyper-coagulable state.
The effect was most pronounced when TXA was administered within three hours of the onset of bleeding.
No increased risk of thromboembolic events (like blood clots) or other adverse effects for mothers or breastfed babies was observed. Dosing and Clinical Application